Biliary Tract Cancer New Indication: Trastuzumab plus CISplatin-Gemcitabine in Biliary Tract Cancers Ulas D. Bayraktar, MD 2023-11-20
Biliary Tract Cancer New Reference: Erdafitinib for Advanced Solid Tumors with FGFR Alterations Ulas D. Bayraktar, MD 2023-09-23
Biliary Tract Cancer New Protocol: Tucatinib and Trastuzumab in her2-Positive Biliary Tract Cancer Ulas D. Bayraktar, MD 2023-06-24
Biliary Tract Cancer New Protocol: Pembrolizumab with CISplatin and Gemcitabine in Metastatic Biliary Tract Cancer Ulas D. Bayraktar, MD 2023-05-20
